Heiko Schuster joined Immatics in 2016 and leads the Target Discovery Unit within the Target Research Department.
The development of novel cancer immunotherapies has been the center of Heiko’s academic and industrial professional life over the last decade. At Immatics, Heiko has led the discovery of cryptic targets and was involved in various aspects of target characterization contributing to the advancement of Immatics’ proprietary XPRESIDENT® platform. Heiko is an inventor on several patents and (co-) authored many publications in the fields of cancer immunology and immunopeptidomics, published in peer-reviewed journals including Nature, Leukemia and PNAS.
Heiko holds a Ph.D. in Biochemistry from the University of Tuebingen.